Clear graft survival and immune reactions following emergency keratoplasty

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 3, 2007, Pages 351-359

  Maier, Philip ^a   Bohringer D ^a   Reinhard, T ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Emergency treatment; Penetrating keratoplasty; Systemic immunosuppression

Indexed keywords

ACETAZOLAMIDE; ACICLOVIR; BETAMETHASONE ACETATE; CYCLOSPORIN A; FLUOCORTOLONE; GENTAMICIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE ACETATE;

ACANTHAMOEBA KERATITIS; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CORNEA EDEMA; CORNEA STROMA; CORNEA ULCER; DRUG BLOOD LEVEL; ELECTIVE SURGERY; EMERGENCY SURGERY; GRAFT FAILURE; GRAFT SURVIVAL; HERPES SIMPLEX KERATITIS; HIGH RISK PATIENT; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MYCOSIS; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CORNEA; CORNEAL DISEASES; CRYOPRESERVATION; CYCLOSPORINE; EMERGENCY TREATMENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; MIDDLE AGED; MYCOPHENOLIC ACID; ORGAN CULTURE TECHNIQUES; ORGAN PRESERVATION; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33947146250     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0410-7     Document Type: Article

References (22)

1. Behrens-Baumann W (1984) [Results of keratoplasty a chaud]. Klin Monatsbl Augenheilkd 185:25-27
2. Bialasiewicz AA, Naumann GO (1989) [Systemic cyclosporin A therapy in high risk keratoplasty]. Fortschr Ophthalmol 86:574-580
3. Cobo LM, Coster DJ, Rice NS, Jones BR (1980) Prognosis and management of corneal transplantation for herpetic keratitis. Arch Ophthalmol 98:1755-1759
4. Ficker LA, Kirkness CM, Rice NS, Steele AD (1989) The changing management and improved prognosis for corneal grafting in herpes simplex keratitis. Ophthalmology 96:1587-1596
5. Ficker LA, Kirkness C, Wright P (1993) Prognosis for keratoplasty in acanthamoeba keratitis. Ophthalmology 100:105-110
6. Fine M, Cignetti FE (1977) Penetrating keratoplasty in herpes simplex keratitis. Recurrence in grafts. Arch Ophthalmol 95:613-616
7. Foster CS, Duncan J (1981) Penetrating keratoplasty for herpes simplex keratitis. Am J Ophthalmol 92:336-343
8. Hill JC (1994) Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. Ophthalmology 101:128-133
9. Hoffmann F (1976) [Suture technique for perforating keratoplasty (author's transl)]. Klin Monatsbl Augenheilkd 169:584-590
10. Killingsworth DW, Stern GA, Driebe WT, Knapp A, Dragon DM (1993) Results of therapeutic penetrating keratoplasty. Ophthalmology 100:534-541
11. Kirkness CM, Ficker LA, Steele AD, Rice NS (1991) The role of penetrating keratoplasty in the management of microbial keratitis. Eye 5 (Pt 4):425-431
12. Mayer K, Reinhard T, Reis A, Voiculescu A, Sundmacher R (2003) Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: First results of a randomised pilot study. Graefes Arch Clin Exp Ophthalmol 241:1051-1054
13. Nobe JR, Moura BT, Robin JB, Smith RE (1990) Results of penetrating keratoplasty for the treatment of corneal perforations. Arch Ophthalmol 108:939-941
14. Polack FM, Kaufman HE (1972) Penetrating keratoplasty in herpetic keratitis. Am J Ophthalmol 73:908-913
15. Price FW Jr, Whitson WE, Johns S, Gonzales JS (1996) Risk factors for corneal graft failure. J Refract Surg 12:134-143; discussion 143-147
16. Reinhard T, Reis A, Bohringer D, Malinowski M, Voiculescu A, Heering P, Godehardt E, Sunmacher R (2001) Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial. Graefes Arch Clin Exp Ophthalmol 239:367-372
17. Reinhard T, Sundmacher R (1992) [Perforating keratoplasty in endogenous eczema. An indication for systemic cyclosporin A-a retrospective study of 18 patients]. Klin Monatsbl Augenheilkd 201:159-163
18. Reinhard T, Sundmacher R, Godehardt E, Heering P (1997) [Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor]. Ophthalmologe 94:496-500
19. Reinhard T, Sundmacher R, Heering P (1996) Systemic ciclosporin A in high-risk keratoplasties. Graefes Arch Clin Exp Ophthalmol 234 Suppl 1:S115-S121
20. Reis A, Reinhard T, Voiculescu A, Kutkuhn B, Godehardt E, Spelsberg H, Althaus C, Sundmacher R (1999) Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: A prospectively randomised clinical trial. Br J Ophthalmol 83:1268-1271
21. Stubiger N, Pleyer U, Erb C, Thiel HJ (1995) [Keratoplasty a chaud]. Ophthalmologe 92:427-432
22. Volker-Dieben HJ, Kok-van Alphen CC, D'Amaro J, de Lange P (1984) The effect of prospective HLA-A and -B matching in 288 penetrating keratoplasties for herpes simplex keratitis. Acta Ophthalmol (Copenh) 62:513-523